Avricore Health (AVCRF) Cash & Current Investments (2013 - 2025)
Avricore Health (AVCRF) reported Cash & Current Investments of $812022.8 for Q4 2025, up 310.15% year-over-year from $197983.1 in Q4 2024, and up 110.16% quarter-over-quarter from $386389.6 in Q3 2025.
Avricore Health (AVCRF) Cash & Current Investments (2013 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 13 years of Cash & Current Investments data on file, last reported at $812022.8 in Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $812022.8, up 310.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $812022.8 (up 310.15% YoY), and the FY2025 annual result was $810477.2, up 301.21% from the prior year.
- Cash & Current Investments grew to $812022.8 in Q4 2025 per AVCRF's latest filing, from $386389.6 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $2.1 million in Q2 2021 and troughed at $197983.1 in Q4 2024.
- A 5-year average of $889974.5 and a median of $540035.7 in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2021 and 2022: Cash & Current Investments surged 5477.08% in 2021, then plunged 75.19% in 2022.
- A 5-year view of Cash & Current Investments shows it stood at $1.8 million in 2021, then sank by 75.19% to $457144.1 in 2022, then decreased by 0.29% to $455799.1 in 2023, then slumped by 56.56% to $197983.1 in 2024, then jumped by 310.15% to $812022.8 in 2025.
- Business Quant data shows AVCRF's Cash & Current Investments at $812022.8 in Q4 2025, $386389.6 in Q3 2025, and $617201.3 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 462.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 5.70 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 200.53 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 1.81 Bn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 2.10 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 1.10 Bn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 1.16 Bn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 60.60 Mn |
| 10 | Avricore Health | - | - | - | 812,022.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 812,022.77 |
| Sep 30, 2025 | 386,389.62 |
| Jun 30, 2025 | 617,201.31 |
| Mar 31, 2025 | 884,878.33 |
| Dec 31, 2024 | 197,983.11 |
| Sep 30, 2024 | 202,741.31 |
| Jun 30, 2024 | 202,212.27 |
| Mar 31, 2024 | 205,246.99 |
| Dec 31, 2023 | 455,799.13 |
| Sep 30, 2023 | 462,870.00 |
| Jun 30, 2023 | 461,952.85 |
| Mar 31, 2023 | 459,001.57 |
| Dec 31, 2022 | 457,144.07 |
| Sep 30, 2022 | 904,092.73 |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 2.12 Mn |
| Mar 31, 2021 | 2.04 Mn |